BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27528012)

  • 1. Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis.
    Chen J; Gong X; Chen P; Luo K; Zhang X
    BMC Pregnancy Childbirth; 2016 Aug; 16():225. PubMed ID: 27528012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis.
    Rakhanova Y; Almawi WY; Aimagambetova G; Riethmacher D
    BMC Pregnancy Childbirth; 2023 Jun; 23(1):409. PubMed ID: 37268873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
    Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
    JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial.
    Maged M; Wageh A; Shams M; Elmetwally A
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):483-486. PubMed ID: 30122565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
    Groom KM; McCowan LM; Mackay LK; Lee AC; Gardener G; Unterscheider J; Sekar R; Dickinson JE; Muller P; Reid RA; Watson D; Welsh A; Marlow J; Walker SP; Hyett J; Morris J; Stone PR; Baker PN
    BJOG; 2019 Jul; 126(8):997-1006. PubMed ID: 30779295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial.
    Winer N; Branger B; Azria E; Tsatsaris V; Philippe HJ; Rozé JC; Descamps P; Boog G; Cynober L; Darmaun D
    Clin Nutr; 2009 Jun; 28(3):243-8. PubMed ID: 19359073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
    Liauw J; Groom K; Ganzevoort W; Gluud C; McKinlay CJD; Sharp A; Mackay L; Kariya C; Lim K; von Dadelszen P; Limpens J; Jakobsen JC;
    Syst Rev; 2021 Dec; 10(1):305. PubMed ID: 34861900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
    Sharp A; Cornforth C; Jackson R; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z;
    Lancet Child Adolesc Health; 2018 Feb; 2(2):93-102. PubMed ID: 30169244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-arginine supplementation improved neonatal outcomes in pregnancies with hypertensive disorder or intrauterine growth restriction: A systematic review and meta-analysis of randomized controlled trials.
    Xu L; Wang X; Wang C; Li W; Liu H
    Clin Nutr; 2022 Jul; 41(7):1512-1522. PubMed ID: 35667267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.
    Pels A; Kenny LC; Alfirevic Z; Baker PN; von Dadelszen P; Gluud C; Kariya CT; Mol BW; Papageorghiou AT; van Wassenaer-Leemhuis AG; Ganzevoort W; Groom KM;
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):440. PubMed ID: 29282009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial.
    Shehata NAA; Ali HAA; Fahim AS; Katta MA; Hussein GK
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1631-1637. PubMed ID: 30345864
    [No Abstract]   [Full Text] [Related]  

  • 13. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction.
    von Dadelszen P; Dwinnell S; Magee LA; Carleton BC; Gruslin A; Lee B; Lim KI; Liston RM; Miller SP; Rurak D; Sherlock RL; Skoll MA; Wareing MM; Baker PN;
    BJOG; 2011 Apr; 118(5):624-8. PubMed ID: 21392225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.
    Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C
    Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.
    Ganzevoort W; Alfirevic Z; von Dadelszen P; Kenny L; Papageorghiou A; van Wassenaer-Leemhuis A; Gluud C; Mol BW; Baker PN
    Syst Rev; 2014 Mar; 3():23. PubMed ID: 24618418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis.
    Ferreira RDDS; Negrini R; Bernardo WM; Simões R; Piato S
    PLoS One; 2019; 14(7):e0219732. PubMed ID: 31339910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices.
    Trapani A; Gonçalves LF; Trapani TF; Franco MJ; Galluzzo RN; Pires MM
    Ultrasound Obstet Gynecol; 2016 Jul; 48(1):61-5. PubMed ID: 26279411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sildenafil in Nω-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model.
    Nassar AH; Masrouha KZ; Itani H; Nader KA; Usta IM
    Am J Perinatol; 2012 Jun; 29(6):429-34. PubMed ID: 22399207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sildenafil citrate on feto-placental development and haemodynamics in a rabbit model of intrauterine growth restriction.
    López-Tello J; Arias-Álvarez M; Jiménez-Martínez MÁ; Barbero-Fernández A; García-García RM; Rodríguez M; Lorenzo PL; Torres-Rovira L; Astiz S; González-Bulnes A; Rebollar PG
    Reprod Fertil Dev; 2017 Jun; 29(6):1239-1248. PubMed ID: 27209378
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.